所属 |
フロンティア科学総合研究センター 生理活性物質研究部門生理活性物質探索病態解析分野 |
職名 |
准教授 |
外部リンク |
論文 【 表示 / 非表示 】
-
Jiang D, Matsuzaki M, Ida T, Kitamura K, Kato J
Hypertension research : official journal of the Japanese Society of Hypertension 47 ( 4 ) 1017 - 1023 2024年2月
記述言語:英語 掲載種別:研究論文(学術雑誌) 出版者・発行元:Springer Nature
Increased blood pressure variability (BPV) was shown to be associated with cardiovascular morbidities and/or mortalities. There are various types of BPV depending on time intervals of BP measurements, ranging from beat-to-beat to visit-to-visit or year-to-year. We previously found that continuous infusion of noradrenaline (NA) for 14 days increased short-term BPV every 15 min in rats. The aims of this study were to examine (1) whether NA infusion increases very short-term beat-to-beat BPV, (2) the effects of azelnidipine and hydralazine on NA-induced BPV, and (3) whether baroreceptor reflex sensitivity (BRS) is affected by NA or NA plus those vasodilators. Nine-week-old Wistar rats infused subcutaneously with 30 μg/h NA were orally treated with or without 9.7 mg/day azelnidipine or 5.9 mg/day hydralazine over 14 days. BP levels were continuously monitored via abdominal aortic catheter with a telemetry system in an unrestrained condition. Standard deviations (SDs) were used to evaluate beat-to-beat BPV and BPV every 15 min which was obtained by averaging BP levels for 10-s segment at each time point. BRS was determined by a sequence analysis. Continuous NA infusion over 14 days increased average BP, beat-to-beat BPV, and BPV every 15 min, lowering BRS. Comparing the two vasodilators, hydralazine reduced BP elevation by NA; meanwhile, azelnidipine alleviated BPV augmentation, preserving BRS, despite a smaller BP reduction. Thus, NA infusion increased both very short- and short-term BPV concomitantly with impaired BRS, while azelnidipine had an inhibitory effect, possibly independent of BP-lowering, on those types of BPV and impairment of BRS.
-
Diversity of Androgens; Comparison of Their Significance and Characteristics in Vertebrate Species 査読あり
Yazawa T., Imamichi Y., Sato T., Ida T., Umezawa A., Kitano T.
Zoological Science 41 ( 1 ) 77 - 86 2024年1月
記述言語:英語 掲載種別:研究論文(学術雑誌) 出版者・発行元:Zoological Science
Androgen(s) is one of the sex steroids that are involved in many physiological phenomena of vertebrate species. Although androgens were originally identified as male sex hormones, it is well known now that they are also essential in females. As in the case of other steroid hormones, androgen is produced from cholesterol through serial enzymatic reactions. Although testis is a major tissue to produce androgens in all species, androgens are also produced in ovary and adrenal (interrenal tissue). Testosterone is the most common and famous androgen. It represents a major androgen both in males and females of almost vertebrate species. In addition, testosterone is a precursorforproducingsignificantandrogenssuchas11-ketotestosterone,5α-dihydrotestosterone, 11-ketodihydrotestosterones and 15α-hydroxytestosterone in a species- or sex-dependent manner for their homeostasis. In this article, we will review the significance and characteristics of these androgens, following a description of the history of testosterone discovery and its synthetic pathways.
DOI: 10.2108/zs230064
-
Izumi T., Saito A., Ida T., Mukuda T., Katayama Y., Wong M.K.S., Tsukada T.
Cell and Tissue Research 396 ( 2 ) 197 - 212 2024年
記述言語:英語 掲載種別:研究論文(学術雑誌) 出版者・発行元:Cell and Tissue Research
The natriuretic peptide (NP) family consists of cardiac NPs (ANP, BNP, and VNP) and brain NPs (CNPs) in teleosts. In addition to CNP1-4, a paralogue of CNP4 (named CNP4b) was recently discovered in basal teleosts including Japanese eel. Mammals have lost most Cnps during the evolution, but teleost cnps were conserved and diversified, suggesting that CNPs are important hormones for maintaining brain functions in teleost. The present study evaluated the potency of each Japanese eel CNP to their NP receptors (NPR-A, NPR-B, NPR-C, and NPR-D) overexpressed in CHO cells. A comprehensive brain map of cnps- and nprs-expressing neurons in Japanese eel was constructed by integrating the localization results obtained by in situ hybridization. The result showed that CHO cells expressing NPR-A and NPR-B induced strong cGMP productions after stimulation by cardiac and brain NPs, respectively. Regarding brain distribution of cnps, cnp1 is engaged in the ventral telencephalic area and periventricular area including the parvocellular preoptic nucleus (Pp), anterior/posterior tuberal nuclei, and periventricular gray zone of the optic tectum. cnp3 is found in the habenular nucleus and prolactin cells in the pituitary. cnp4 is expressed in the ventral telencephalic area, while cnp4b is expressed in the motoneurons in the medullary area. Such CNP isoform-specific localizations suggest that function of each CNP has diverged in the eel brain. Furthermore, the Pp lacking the blood-brain barrier expressed both npra and nprb, suggesting that endocrine and paracrine NPs interplay for regulating the Pp functions in Japanese eels.
-
Acyl modifications in bovine, porcine, and equine ghrelins 査読あり
Ida T., Tominaga H., Iwamoto E., Kurogi A., Okura A., Shimada K., Kato J., Kuwano A., Ode H., Nagata S., Kitamura K., Yazawa T., Sato-Hashimoto M., Yasuda M., Miyazato M., Shiimura Y., Sato T., Kojima M.
Frontiers in Endocrinology 15 1411483 2024年
記述言語:英語 掲載種別:研究論文(学術雑誌) 出版者・発行元:Frontiers in Endocrinology
Ghrelin is a peptide hormone with various important physiological functions. The unique feature of ghrelin is its serine 3 acyl-modification, which is essential for ghrelin activity. The major form of ghrelin is modified with n-octanoic acid (C8:0) by ghrelin O-acyltransferase. Various acyl modifications have been reported in different species. However, the underlying mechanism by which ghrelin is modified with various fatty acids remains to be elucidated. Herein, we report the purification of bovine, porcine, and equine ghrelins. The major active form of bovine ghrelin was a 27-amino acid peptide with an n-octanoyl (C8:0) modification at Ser3. The major active form of porcine and equine ghrelin was a 28-amino acid peptide. However, porcine ghrelin was modified with n-octanol (C8:0), whereas equine ghrelin was modified with n-butanol (C4:0) at Ser3. This study indicates the existence of structural divergence in ghrelin and suggests that it is necessary to measure the minor and major forms of ghrelin to fully understand its physiology.
-
Natriuretic peptides potentiate cardiac hypertrophic response to noradrenaline in rats 査読あり
Jiang D., Matsuzaki M., Ida T., Kitamura K., Tsuruda T., Kaikita K., Kato J.
Peptides 166 171035 2023年8月
記述言語:英語 掲載種別:研究論文(学術雑誌) 出版者・発行元:Peptides
Excessive activation of the sympathetic nervous system is involved in cardiovascular damage including cardiac hypertrophy. Natriuretic peptides are assumed to exert protective actions for the heart, alleviating hypertrophy and/or fibrosis of the myocardium. In contrast to this assumption, we show in the present study that both atrial and C-type natriuretic peptides (ANP and CNP) potentiate cardiac hypertrophic response to noradrenaline (NA) in rats. Nine-week-old male Wistar rats were continuously infused with subcutaneous 30 micro-g/h NA without or with persistent intravenous administration of either 1.0 micro-g/h ANP or CNP for 14 days. Blood pressure (BP) was recorded under an unrestrained condition by a radiotelemetry system. Cardiac hypertrophic response to NA was evaluated by heart weight/body weight (HW/BW) ratio and microscopic measurement of myocyte size of the left ventricle. Mean BP levels at the light and dark cycles rose by about 20 mmHg following NA infusion for 14 days, with slight increases in HW/BW ratio and ventricular myocyte size. Infusions of ANP and CNP had no significant effects on mean BP in NA-infused rats, while two natriuretic peptides potentiated cardiac hypertrophic response to NA. Cardiac hypertrophy induced by co-administration of NA and ANP was attenuated by treatment with prazosin or atenolol. In summary, both ANP and CNP potentiated cardiac hypertrophic effect of continuously infused NA in rats, suggesting a possible pro-hypertrophic action of natriuretic peptides on the heart.
MISC 【 表示 / 非表示 】
-
消化管関連ペプチドが拓く恒常性フロンティア 招待あり
佐藤貴弘、井田隆徳、関口俊男、中町智哉、児島将康
実験医学 37 ( 3 ) 1 - 8 2019年
記述言語:日本語 掲載種別:記事・総説・解説・論説等(商業誌、新聞、ウェブメディア)
-
Role of biological rhythms in the performance of physical activity 招待あり 査読あり
Sato T, Ida T, Kojima M
The Journal of Physical Fitness and Sports Medicine 6 ( 3 ) 125 - 134 2017年3月
記述言語:英語 掲載種別:記事・総説・解説・論説等(学術雑誌)
-
モデル生物を利用した新規摂食調節ペプチドの探索
井田隆徳
生物科学 2016年3月
記述言語:日本語 掲載種別:記事・総説・解説・論説等(学術雑誌) 出版者・発行元:農山漁村文化協会
-
Sano H., Nakamura A., Texada M., Truman J., Ishimoto H., Kamikouchi A., Nibu Y., Kume K., Ida T., Kojima M.
PLoS Genetics 11 ( 9 ) 2015年9月
-
摂食調節ペプチドと飢餓応答
佐藤貴弘、井田隆徳、児島将康
The lipid 26 ( 1 ) 35 - 39 2015年1月
記述言語:日本語 掲載種別:記事・総説・解説・論説等(商業誌、新聞、ウェブメディア) 出版者・発行元:メディカルレビュー社
講演・口頭発表等 【 表示 / 非表示 】
-
動物介在活動から考えるOne Health 招待あり
井田隆徳
第166回日本獣医学会学術集会
開催年月日: 2023年9月5日
会議種別:口頭発表(一般)
-
新規生理活性ペプチドの探索と応用 招待あり
井田隆徳
第70回日本心臓病学会学術集会 2022年9月23日
開催年月日: 2022年9月23日
記述言語:日本語 会議種別:口頭発表(一般)
-
ホルモンとライフステージ:生物の生理学的変化と適応のダイナミズム
井田隆徳、長谷川和哉
第101回日本生理学会大会
開催年月日: 2024年3月28日
会議種別:シンポジウム・ワークショップ パネル(公募)
-
ウナギ脳に作用するナトリウム利尿ペプチドの内分泌・傍分泌経路の特定
和泉知輝、齋藤あみ、井田隆徳、椋田崇生、片山侑駿、Marty Kwok-Shing Wong、塚田岳大
第47回日本比較内分泌学会大会
開催年月日: 2023年11月17日
会議種別:口頭発表(一般)
-
新規生理活性ペプチドの探索
井田隆徳
第13回ペプチド・ホルモン研究会
開催年月日: 2023年9月30日
会議種別:口頭発表(一般)
受賞 【 表示 / 非表示 】
-
日本獣医学会生理学・生化学分科会奨励賞
2010年9月 日本獣医学会
井田隆徳
受賞区分:国内学会・会議・シンポジウム等の賞 受賞国:日本国
-
11th International Conference on Human-Animal Interactions.Best Poster Award
2007年10月 IAHAIO
Yoshidomi Y, Ikeda Y, Satoh H, Sekino R, Ida T, Hisatomi I, Nakatsuka K, Misawa N
受賞区分:国際学会・会議・シンポジウム等の賞 受賞国:日本国
科研費(文科省・学振・厚労省)獲得実績 【 表示 / 非表示 】
-
摂食・エネルギー代謝を制御する新規生理活性ペプチドの発見と応用
研究課題/領域番号:21K05958 2021年04月 - 2024年03月
独立行政法人日本学術振興会 科学研究費補助金 基盤研究C
担当区分:研究代表者
-
生体必須の金属補因子「鉄硫黄クラスター」の生合成機序と無細胞構築系の確立
研究課題/領域番号:20H03196 2020年04月 - 2024年03月
独立行政法人日本学術振興会 科学研究費補助金 基盤研究(B)
担当区分:研究分担者
-
難治性の神経因性疼痛を抑制する脳由来新規生理活性物質の構造決定と生理作用の解析
研究課題/領域番号:20K07768 2020年04月 - 2023年03月
独立行政法人日本学術振興会 科学研究費補助金 基盤研究(C)
担当区分:研究分担者
-
新規NPY様RYamideペプチドの発見と食欲調節機構の解析
2017年04月 - 2020年03月
科学研究費補助金 基盤研究(C)
担当区分:研究代表者
-
昆虫における食欲促進/減退を引き起こす生理活性ペプチドの発見
2014年04月 - 2017年03月
科学研究費補助金 基盤研究(C)
担当区分:研究代表者
昆虫における食欲促進/減退を引き起こす生理活性ペプチドの発見し解析する
その他競争的資金獲得実績 【 表示 / 非表示 】
-
新規生理活性ペプチドの探索
2010年01月 - 2015年03月
文部科学省 特色ある大学教育支援プログラム
担当区分:研究代表者 資金種別:競争的資金
新規生理活性ペプチドの探索
その他研究活動 【 表示 / 非表示 】
-
食鳥処理施設での骨髄のサンプリング
2023年11月
-
食鳥処理施設での脳のサンプリング
2019年07月
-
食鳥処理施設での肝臓のサンプリング
2018年06月
-
食肉処理施設における膵臓のサンプリング
2017年07月
-
食鳥処理施設での脳のサンプリング
2017年05月
研究・技術シーズ 【 表示 / 非表示 】
-
新規生理活性ペプチドの探索
新規生理活性ペプチドの機能解析
病態モデル生物の作製技術相談に応じられる関連分野:ペプチド抽出
受容体発現細胞を用いたセカンドメッセンジャーアッセイメッセージ:宮崎大学の伝統あるペプチド研究を引き継ぎ、ペプチド研究におけるプラットフォームを目指しています。